Literature DB >> 23685934

Plasmablastic lymphoma after standard-dose temozolomide for newly diagnosed glioblastoma.

Stephen W Clark1, Jennie Taylor, Daphne L Wang, Jeremy S Abramson, Tracy T Batchelor.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23685934      PMCID： PMC3770207          DOI： 10.1212/WNL.0b013e318297eea6

Source DB:  PubMed          Journal:  Neurology        ISSN： 0028-3878            Impact factor:   9.910


× No keyword cloud information.
  7 in total

1.  Non-Hodgkin's lymphoma in patients with glioma treated with temozolomide.

Authors:  Bart Neyns; Susanna Cordera; Eric Joosens; Nader Pouratian; Pouratian Nader
Journal:  J Clin Oncol       Date:  2008-09-20       Impact factor: 44.544

2.  Randomized phase III study of temozolomide versus dacarbazine in the treatment of patients with advanced metastatic malignant melanoma.

Authors:  M R Middleton; J J Grob; N Aaronson; G Fierlbeck; W Tilgen; S Seiter; M Gore; S Aamdal; J Cebon; A Coates; B Dreno; M Henz; D Schadendorf; A Kapp; J Weiss; U Fraass; P Statkevich; M Muller; N Thatcher
Journal:  J Clin Oncol       Date:  2000-01       Impact factor: 44.544

Review 3.  Dose-dense temozolomide regimens: antitumor activity, toxicity, and immunomodulatory effects.

Authors:  Bart Neyns; Alicia Tosoni; Wen-Jen Hwu; David A Reardon
Journal:  Cancer       Date:  2010-06-15       Impact factor: 6.860

Review 4.  Treatment-related myelodysplasia in patients with primary brain tumors.

Authors:  Joachim M Baehring; Peter W Marks
Journal:  Neuro Oncol       Date:  2012-03-29       Impact factor: 12.300

5.  Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma.

Authors:  Roger Stupp; Warren P Mason; Martin J van den Bent; Michael Weller; Barbara Fisher; Martin J B Taphoorn; Karl Belanger; Alba A Brandes; Christine Marosi; Ulrich Bogdahn; Jürgen Curschmann; Robert C Janzer; Samuel K Ludwin; Thierry Gorlia; Anouk Allgeier; Denis Lacombe; J Gregory Cairncross; Elizabeth Eisenhauer; René O Mirimanoff
Journal:  N Engl J Med       Date:  2005-03-10       Impact factor: 91.245

6.  Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray.

Authors:  Christine P Hans; Dennis D Weisenburger; Timothy C Greiner; Randy D Gascoyne; Jan Delabie; German Ott; H Konrad Müller-Hermelink; Elias Campo; Rita M Braziel; Elaine S Jaffe; Zenggang Pan; Pedro Farinha; Lynette M Smith; Brunangelo Falini; Alison H Banham; Andreas Rosenwald; Louis M Staudt; Joseph M Connors; James O Armitage; Wing C Chan
Journal:  Blood       Date:  2003-09-22       Impact factor: 22.113

Review 7.  HIV-associated plasmablastic lymphoma: lessons learned from 112 published cases.

Authors:  Jorge Castillo; Liron Pantanowitz; Bruce J Dezube
Journal:  Am J Hematol       Date:  2008-10       Impact factor: 10.047
  7 in total
  1 in total

Review 1.  Plasmablastic lymphoma following combination treatment with fludarabine and rituximab for nongastric mucosa-associated lymphoid tissue lymphoma: a case report and review of literature.

Authors:  Jia-Zhu Wu; Ke Min; Lei Fan; Li Wang; Ji Xu; Jian-Yong Li; Wei Xu
Journal:  Int J Clin Exp Pathol       Date:  2014-06-15
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.